top of page
< Back

Ganirelix


Mechanism of action:

Ganirelix is a gonadotropin-releasing hormone antagonist and a synthetic decapeptide. Ganirelix competitively binds to gonadotropin-releasing hormone receptors and blocks the action of endogenous gonadotropin-releasing hormone. Once gonadotropin-releasing hormone signaling is inhibited, secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary rapidly decreases.

Reference(s):

1. Gillies PS et al. (2000). Ganirelix. Drugs. 


2. Out HJ et al. (2002). The gonadotrophin-releasing hormone antagonist ganirelix—history and introductory data. Hum Fertil (Camb). 


3. Al-Inany HG et al. (2016). Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev.

bottom of page